CD8A and neoplasm: Within the cohort it was found that three of the 10 patients had new responses to treatment with positive changes in the composition of immune cell infiltrates in both the intestinal environment and the TME, including increased CD8+ T cell activation and a decrease in IL-8 expressing cells, signifying a better immune response to the tumor.